Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysosomal and endosomal acidic compartments represent a critical organelle system responsible for the degradation and recycling of cellular materials through the endocytic and autophagic pathways [1]. These compartments maintain a highly acidic internal environment (pH 4.5–6.5) via the activity of vacuolar H+-ATPase (V-ATPase) proton pumps, which is essential for the optimal function of resident acid hydrolases like cathepsins [2]. In oncology, cancer cells often exploit lysosomal biogenesis and acidified compartments to promote nutrient scavenging and resist apoptosis, making them a target for lysosomal membrane permeabilization (LMP) strategies [3]. Furthermore, many viruses, including influenza and coronaviruses, utilize the low pH of endosomes to trigger conformational changes in viral proteins required for membrane fusion and cytosolic entry [4]. Pharmacological intervention typically involves lysosomotropic weak bases, such as chloroquine, which sequester in these compartments, neutralize their acidity, and disrupt pH-dependent maturation and signaling [5]. However, therapeutic use is often limited by systemic safety concerns, including retinal toxicity and cardiac conduction disturbances, necessitating careful monitoring [6]. Sources: [1] Maxfield, F. R., & McGraw, T. E. (2004). Nature Reviews Molecular Cell Biology; [2] Mindell, J. A. (2012). Annual Review of Physiology; [3] Kirkegaard, T., & Jäättelä, M. (2009). Nature Reviews Cancer; [4] Wang, X., et al. (2020). Cell Research; [5] de Duve, C., et al. (1974). Biochemical Pharmacology; [6] Marmor, M. F., et al. (2016). Ophthalmology.
Lysosomotropism leading to pH neutralization, inhibition of acid-dependent hydrolases, and disruption of viral membrane fusion.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal and endosomal acidic compartments.